CM310 for uncontrolled seasonal allergies
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
This study tests a new medicine called CM310 for people whose seasonal allergies are not well controlled by their usual medications. If you join, you'll help see if this treatment can better control your allergy symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be willing to sign a consent form to join the study.
- You should have seasonal allergies that are not well controlled by your current treatments.
- You cannot have any other medical condition that would make it unsafe for you to take part.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injection called MG-K10 for people with moderate-to-severe seasonal hay fever that isn't well controlled by standard treatments like nasal sprays or antihistamines. The goal is to see if it can reduce your allergy symptoms over the pollen season.
This study tests an investigational drug called AK139 to see if it can better control seasonal allergic rhinitis (hay fever) symptoms like sneezing and runny nose. If your symptoms are not well managed with current allergy medicines, this trial might offer a new option.
This trial tests whether acupuncture at a specific spot behind the nose can reduce symptoms from seasonal allergies (triggered by things like grass or birch pollen). It may help if your allergy symptoms are moderate to severe and have lasted for a long time.
This study tests an investigational injection called TQH2722 combined with standard allergy therapy for seasonal allergic rhinitis (hay fever). It may help people whose allergy symptoms are not well controlled during pollen season.
This trial tests a new injection called SHR-1819 for people with seasonal allergies who haven't responded well to standard treatments like nasal sprays or antihistamines. It aims to see if it can reduce allergy symptoms.
This trial tests a new nasal spray designed to relieve the stuffy nose, sneezing, and itching caused by seasonal allergies. It is for people with moderate to severe symptoms that aren’t controlled by other treatments.
Hear when a new Seasonal Allergic Rhinitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.